GlassScriptPhysician profile
Fonda Kay Shaw
NPI 1114038320
$512.03
in general payments reported to CMS, 2019-2025
12 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $94.53 · 2023: $16.82 · 2024: $99.69 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $215.15 | 2021-2025 | |
| Hologic Sales and Service, LLC | $63.43 | 2023-2025 | Aptima |
| Glaxosmithkline, LLC. | $49.34 | 2024-2025 | Bexsero, Shingrix, Arexvy |
| Medtronic, INC. | $37.39 | 2025 | Venaseal |
| Biomarin Pharmaceutical INC. | $24.13 | 2025 | Voxzogo 1.2mg |
| Gilead Sciences, INC. | $21.10 | 2024 | |
| Sanofi Pasteur INC. | $20.95 | 2025 | |
| Exact Sciences Corporation | $17.45 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $17.38 | 2025 | Ozempic, Rybelsus |
| Phadia US INC. | $16.16 | 2024 | Immunocap |
| Alkermes, INC. | $15.30 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fonda Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.